Interestingly, in chronic hyperglycemia, IR, T2D, and obesity, the GIP signaling is impaired and not able to inhibit appetite and metabolic derangements (Bergmann et al. 2019; Thondam et al. 2017). Here, GIP is linked to obesity disorder.